These results indicate that miR-495-3p can inhibit colorectal tumour growth in vivo while HMGB1 promotes tumour growth and further indicate that miR-495-3p can inhibit CRC cell proliferation by targeting HMGB1. Here, HMGB1 is linked to colorectal carcinoma.